Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TYMS Antikörper (AA 60-174)

Der Maus Monoklonal anti-TYMS Antikörper wird verwendet zum Nachweis von TYMS in Proben von Human. Er wurde validiert für WB, IF, FACS und IHC (p).
Produktnummer ABIN5646952
642,40 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für TYMS Antikörper (AA 60-174) (ABIN5646952)

Target

Alle TYMS Antikörper anzeigen
TYMS (Thymidylate Synthetase (TYMS))

Reaktivität

  • 144
  • 40
  • 27
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 73
  • 70
  • 1
Maus

Klonalität

  • 97
  • 47
Monoklonal

Konjugat

  • 71
  • 10
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser TYMS Antikörper ist unkonjugiert

Applikation

  • 77
  • 74
  • 71
  • 49
  • 26
  • 25
  • 19
  • 18
  • 17
  • 15
  • 14
  • 13
  • 12
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Klon

TYMS-1884
  • Bindungsspezifität

    • 30
    • 15
    • 15
    • 5
    • 4
    • 4
    • 4
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 60-174

    Verwendungszweck

    TYMS Antibody / Thymidylate Synthase

    Produktmerkmale

    This antibody recognizes a protein of 36 kDa, identified as Thymidylate Synthase (TS, TYMS). TS converts deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), which is essential for DNA biosynthesis. TS is also a critical target for the fluoropyrimidines, an important group of antineoplastic drugs that are widely used in the treatment of solid tumors. Both 5-FU and fluorodeoxyuridine are converted in tumor cells to FdUMP which inactivates TS by formation of a ternary covalent complex in the presence of the folate cofactor 5,10-methylenetetrahydrofolate. Expression of TS protein is associated with response to 5-fluorouracil (5-FU) in human colorectal, gastric, head and neck, and breast carcinomas.

    Aufreinigung

    Protein G affinity chromatography

    Immunogen

    A recombinant human parital protein corresponding to amino acids 60-174 was used as the immunogen for this TYMS antibody.

    Isotyp

    IgG2c, kappa
  • Applikationshinweise

    The optimal dilution of the TYMS antibody for each application should be determined by the researcher.

    1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    0.2 mg/mL

    Buffer

    0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store the TYMS antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
  • Target

    TYMS (Thymidylate Synthetase (TYMS))

    Andere Bezeichnung

    TYMS

    Hintergrund

    This antibody recognizes a protein of 36 kDa, identified as Thymidylate Synthase (TS, TYMS). TS converts deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), which is essential for DNA biosynthesis. TS is also a critical target for the fluoropyrimidines, an important group of antineoplastic drugs that are widely used in the treatment of solid tumors. Both 5-FU and fluorodeoxyuridine are converted in tumor cells to FdUMP which inactivates TS by formation of a ternary covalent complex in the presence of the folate cofactor 5,10-methylenetetrahydrofolate. Expression of TS protein is associated with response to 5-fluorouracil (5-FU) in human colorectal, gastric, head and neck, and breast carcinomas.

    UniProt

    P04818

    Pathways

    Mitotic G1-G1/S Phases
Sie sind hier:
Chat with us!